Viewing nowCombinationSebaco HCT Tablet 5/40/12.5 mg
Olmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Ajou Pharmaceutical Co., Ltd.

MFDS item code 201906789 · Approved 2019.09.25 · Insurance code 654005510
Improvement in blood pressure control for essential hypertension
The combination therapy of Amlodipine and Olmesartan Medoxomil is used when blood pressure is not adequately controlled in patients with essential hypertension. This treatment helps to dilate blood vessels and effectively lower blood pressure, aiding in the prevention of cardiovascular complications. It assists in maintaining a healthy life through continuous blood pressure control.
This medication should be taken once daily with water, with or without food. It is recommended to take it at the same time every day (e.g., in the morning). The maximum dosage is Amlodipine/Olmesartan Medoxomil/Hydrochlorothiazide at 10/40/25mg. The maximum blood pressure-lowering effect appears within 2 weeks of administration, so dosage adjustments should be made with a minimum interval of 2 weeks. The recommended dosages are as follows: - 5/20 mg
The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established, and its use is not recommended.
This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this drug or its components, those with certain heart, kidney, or liver diseases, or those who are pregnant or breastfeeding. Patients with decreased blood volume or kidney function may experience hypotension or worsening kidney function when taking this medication, and should be monitored closely. As this medication lowers blood pressure, symptoms of hypotension or dizziness may occur; caution is required when driving or operating hazardous machinery. While taking this medication, serum electrolyte levels, especially potassium, sodium, calcium, and magnesium concentrations, should be regularly monitored to prevent electrolyte imbalance. This medication may interact with other drugs, especially with lithium, certain diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs), so consultation with a healthcare professional is recommended. This medication may increase sensitivity of the skin to sunlight; therefore, it is advisable to pay attention to UV protection during treatment, and if photosensitivity reactions occur, contact a doctor immediately. Women who are pregnant or planning to become pregnant should avoid using this medication, and breastfeeding women should either discontinue breastfeeding or consult a physician when using this drug. It is recommended not to use this medication in children under 18 years old as its safety and efficacy are not established. In case of overdose, severe hypotension, palpitations, electrolyte imbalance, and other symptoms may occur, so dosages must be strictly followed and medical attention sought if abnormal symptoms arise. This medication should be stored out of reach of children and kept in a cool place away from direct sunlight and moisture.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory distress accompanied by cough and fever, jaundice (yellowing of skin or eyes), generalized severe lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination abnormalities
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, thus it should be stored in a tightly closed container. It is best to keep it at room temperature between 1 to 30 degrees Celsius. This will help maintain the drug's effectiveness for a longer time.
Pale yellow round film-coated tablet
30 tablets/box [10 tablets/Alu-Alu*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Ajou Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.